BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 18161057)

  • 21. Tamoxifen administration routes and dosage for inducible Cre-mediated gene disruption in mouse hearts.
    Andersson KB; Winer LH; Mørk HK; Molkentin JD; Jaisser F
    Transgenic Res; 2010 Aug; 19(4):715-25. PubMed ID: 19894134
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Integrated microarray and ChIP analysis identifies multiple Foxa2 dependent target genes in the notochord.
    Tamplin OJ; Cox BJ; Rossant J
    Dev Biol; 2011 Dec; 360(2):415-25. PubMed ID: 22008794
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A mouse line expressing Sall1-driven inducible Cre recombinase in the kidney mesenchyme.
    Inoue S; Inoue M; Fujimura S; Nishinakamura R
    Genesis; 2010 Mar; 48(3):207-12. PubMed ID: 20127799
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Efficient recombination in pancreatic islets by a tamoxifen-inducible Cre-recombinase.
    Zhang H; Fujitani Y; Wright CV; Gannon M
    Genesis; 2005 Jul; 42(3):210-7. PubMed ID: 15986486
    [TBL] [Abstract][Full Text] [Related]  

  • 25. miR-335 promotes mesendodermal lineage segregation and shapes a transcription factor gradient in the endoderm.
    Yang D; Lutter D; Burtscher I; Uetzmann L; Theis FJ; Lickert H
    Development; 2014 Feb; 141(3):514-25. PubMed ID: 24449834
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Generation of the tamoxifen-inducible DBH-Cre transgenic mouse line DBH-CT.
    Stubbusch J; Majdazari A; Schmidt M; Schütz G; Deller T; Rohrer H
    Genesis; 2011 Dec; 49(12):935-41. PubMed ID: 21634003
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Ligand-dependent genetic recombination in fibroblasts : a potentially powerful technique for investigating gene function in fibrosis.
    Zheng B; Zhang Z; Black CM; de Crombrugghe B; Denton CP
    Am J Pathol; 2002 May; 160(5):1609-17. PubMed ID: 12000713
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Foxh1 and Foxa2 are not required for formation of the midgut and hindgut definitive endoderm.
    McKnight KD; Hou J; Hoodless PA
    Dev Biol; 2010 Jan; 337(2):471-81. PubMed ID: 19896480
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Transgenic mice expressing tamoxifen-inducible Cre for somatic gene modification in renal epithelial cells.
    Lantinga-van Leeuwen IS; Leonhard WN; van de Wal A; Breuning MH; Verbeek S; de Heer E; Peters DJ
    Genesis; 2006 May; 44(5):225-32. PubMed ID: 16652363
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A mouse tool for conditional mutagenesis in ovarian granulosa cells.
    Grabner B; Blaas L; Musteanu M; Hoffmann T; Birbach A; Eferl R; Casanova E
    Genesis; 2010 Oct; 48(10):612-7. PubMed ID: 20715176
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Conditional tamoxifen Cre induced mutagenesis in the embryonic kidney in organ culture.
    Jokela T; Vainio S
    Genesis; 2007 Dec; 45(12):757-61. PubMed ID: 18064673
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A practical summary of site-specific recombination, conditional mutagenesis, and tamoxifen induction of CreERT2.
    Anastassiadis K; Glaser S; Kranz A; Berhardt K; Stewart AF
    Methods Enzymol; 2010; 477():109-23. PubMed ID: 20699139
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Generation of Mouse for Conditional Expression of Forkhead Box A2.
    Wang P; Wu SP; Brooks KE; Kelleher AM; Milano-Foster JJ; DeMayo FJ; Spencer TE
    Endocrinology; 2018 Apr; 159(4):1897-1909. PubMed ID: 29546371
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Optimization of tamoxifen-induced Cre activity and its effect on immune cell populations.
    Donocoff RS; Teteloshvili N; Chung H; Shoulson R; Creusot RJ
    Sci Rep; 2020 Sep; 10(1):15244. PubMed ID: 32943672
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Optimization of spatiotemporal gene inactivation in mouse heart by oral application of tamoxifen citrate.
    Kiermayer C; Conrad M; Schneider M; Schmidt J; Brielmeier M
    Genesis; 2007 Jan; 45(1):11-6. PubMed ID: 17216603
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cre-loxP DNA recombination is possible with only minimal unspecific transcriptional changes and without cardiomyopathy in Tg(alphaMHC-MerCreMer) mice.
    Hougen K; Aronsen JM; Stokke MK; Enger U; Nygard S; Andersson KB; Christensen G; Sejersted OM; Sjaastad I
    Am J Physiol Heart Circ Physiol; 2010 Nov; 299(5):H1671-8. PubMed ID: 20802136
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A shortened tamoxifen induction scheme to induce CreER recombinase without side effects on the male mouse skeleton.
    Jardí F; Laurent MR; Dubois V; Khalil R; Deboel L; Schollaert D; Van Den Bosch L; Decallonne B; Carmeliet G; Claessens F; Vanderschueren D
    Mol Cell Endocrinol; 2017 Sep; 452():57-63. PubMed ID: 28504114
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Foxa2 is essential for mouse endometrial gland development and fertility.
    Jeong JW; Kwak I; Lee KY; Kim TH; Large MJ; Stewart CL; Kaestner KH; Lydon JP; DeMayo FJ
    Biol Reprod; 2010 Sep; 83(3):396-403. PubMed ID: 20484741
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Temporal control of gene recombination in astrocytes by transgenic expression of the tamoxifen-inducible DNA recombinase variant CreERT2.
    Hirrlinger PG; Scheller A; Braun C; Hirrlinger J; Kirchhoff F
    Glia; 2006 Jul; 54(1):11-20. PubMed ID: 16575885
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Sox17-2A-iCre: a knock-in mouse line expressing Cre recombinase in endoderm and vascular endothelial cells.
    Engert S; Liao WP; Burtscher I; Lickert H
    Genesis; 2009 Sep; 47(9):603-10. PubMed ID: 19548312
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.